Mechanistically, miR-21 promotes oncogenesis by targeting the tumor suppressor PTEN, leading to activation of the PI3K/AKT signaling cascade, which enhances cell survival, proliferation, and resistance to therapy [75,76,77,84]. The gene discussed is PTEN; the disease is neoplasm.